Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Giraud-Baro, Elisabeth
Dassa, Daniel
De Vathaire, Florent
Garay, Ricardo P.
and
Obeid, Joelle
2016.
Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study).
BMC Psychiatry,
Vol. 16,
Issue. 1,
Joshi, Kruti
Lin, Jay
Lingohr-Smith, Melissa
Fu, Dong-Jing
and
Muser, Erik
2016.
Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States.
Journal of Clinical Psychopharmacology,
Vol. 36,
Issue. 5,
p.
429.
Suzuki, Takefumi
2016.
A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.
Expert Opinion on Drug Delivery,
Vol. 13,
Issue. 2,
p.
253.
Williams, Wesley
McKinney, Christopher
Martinez, Larry
and
Benson, Carmela
2016.
Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery.
Journal of Medical Economics,
Vol. 19,
Issue. 5,
p.
469.
Awad, George
Ng-Mak, Daisy
Rajagopalan, Krithika
Hsu, Jay
Pikalov, Andrei
and
Loebel, Antony
2016.
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
BMC Psychiatry,
Vol. 16,
Issue. 1,
Rofail, Diana
Regnault, Antoine
le Scouiller, Stéphanie
Berardo, Carmen Galani
Umbricht, Daniel
and
Fitzpatrick, Ray
2016.
Health-related quality of life in patients with prominent negative symptoms: results from a multicenter randomized Phase II trial on bitopertin.
Quality of Life Research,
Vol. 25,
Issue. 1,
p.
201.
Park, Seon-Cheol
Choi, Mi Young
Choi, Jina
Park, Eunjung
Tchoe, Ha Jin
Suh, Jae Kyung
Kim, Young Hoon
Won, Seung Hee
Chung, Young-Chul
Bae, Kyung-Yeol
Lee, Sang-Kyu
Park, Chan Mi
and
Lee, Seung-Hwan
2018.
Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis.
Clinical Psychopharmacology and Neuroscience,
Vol. 16,
Issue. 4,
p.
361.
Domenech, Cristina
Altamura, Carlo
Bernasconi, Corrado
Corral, Ricardo
Elkis, Helio
Evans, Jonathan
Malla, Ashok
Krebs, Marie-Odile
Nordstroem, Anna-Lena
Zink, Mathias
and
Haro, Josep Maria
2018.
Health-related quality of life in outpatients with schizophrenia: factors that determine changes over time.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 53,
Issue. 3,
p.
239.
Harvey, Philip D.
Strassnig, Martin T.
and
Silberstein, Juliet
2019.
Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment.
Journal of Experimental Psychopathology,
Vol. 10,
Issue. 3,
p.
204380871986569.
Olagunju, Andrew T
Clark, Scott R
and
Baune, Bernhard T
2019.
Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome.
Australian & New Zealand Journal of Psychiatry,
Vol. 53,
Issue. 6,
p.
509.
McDonagh, Marian S.
Dana, Tracy
Selph, Shelley
Devine, Emily B.
Cantor, Amy
Bougatsos, Christina
Blazina, Ian
Grusing, Sara
Fu, Rongwei
and
Haupt, Daniel W.
2020.
Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia.
Psychiatric Research and Clinical Practice,
Vol. 2,
Issue. 2,
p.
76.
Sampogna, Gaia
Di Vincenzo, Matteo
Giuliani, Luigi
Menculini, Giulia
Mancuso, Emiliana
Arsenio, Eleonora
Cipolla, Salvatore
Della Rocca, Bianca
Martiadis, Vassilis
Signorelli, Maria Salvina
and
Fiorillo, Andrea
2023.
A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia.
Brain Sciences,
Vol. 13,
Issue. 11,
p.
1577.